To repair the disorders of immune homeostasis and tolerance, Santucci et al. found that galectin-1 significantly improved the histopathologic and clinical features of 2,4,6-trinitrobenzene sulfonic acid-induced experimental colitis [126]. The gene discussed is LGALS1; the disease is colitis.